THE RELATIVE SAFETY OF A PROMISING TRIPLE DRUG MASS DRUG ADMINISTRATION REGIMEN VERSUS A TWO-DRUG REGIMEN FOR LYMPHATIC FILARIASIS ELIMINATION IN INDIA

被引:0
|
作者
Purushothaman, Jambulingam [1 ]
Kuttiatt, Vijesh [1 ]
Swaminathan, Subramanian [1 ]
Kaliannagounder, Krishnamoorthy [1 ]
Adinarayanan, Srividya [1 ]
Weil, Gary [2 ]
机构
[1] Vector Control Res Ctr, ICMR, Pondicherry, India
[2] Washington Univ, Sch Med, St Louis, MO USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1951
引用
收藏
页码:614 / 614
页数:1
相关论文
共 50 条
  • [21] Alternative drug regimens and mass drug administration strategies for lymphatic filariasis and onchocerciasis elimination programmes
    Weil, G. J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 28 - 28
  • [22] Coverage evaluation of mass drug administration with triple drug regimen in an evaluation unit in Nagpur district of Maharashtra, India
    Dinesh, Raja Jeyapal
    Srividya, Adinarayanan
    Subramanian, Swaminathan
    Krishnamoorthy, Kaliannagounder
    Sabesan, Shanmugavelu
    Raghorte, Monika Charmode
    Kumar, Ashwani
    Jambulingam, Purushothaman
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (09):
  • [23] COMMUNITY RANDOMIZED SAFETY TRIAL OF TRIPLE- DRUG MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS IN PAPUA NEW GUINEA
    Tavul, Livingstone
    Howard, Samuel
    Laman, Moses
    Kumai, Steven
    Samuel, Anna
    Kotty, Bethuel
    Lorry, Lina
    Makita, Leo
    Yohogu, Mary
    John, Lucy
    Bieb, Sibauk
    Wangi, James
    Siba, Peter
    Bogus, Joshua
    O'Brian, Katiuscia
    Kazura, James
    Weil, Gary J.
    Tisch, Daniel
    King, Christopher L.
    Robinson, Leanne J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 239 - 239
  • [24] Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment
    Cattaneo, Dario
    Capetti, Amedeo
    Rizzardini, Giuliano
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (03) : 245 - 252
  • [25] Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia - American Samoa, 2019
    Hast, Marisa A.
    Tufa, Aifili
    Brant, Tara A.
    Suiaunoa-Scanlan, Lynette
    Camacho, Janet
    Vaifanua-Leo, June
    Robinson, Keri
    Dodd, Emily
    Sili, Ben
    Lees, Loretta S.
    Won, Kimberly Y.
    Utu, Fara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (21): : 656 - 657
  • [26] The Impact of Mass Drug Administration on Lymphatic Filariasis
    Aboagye, Isaac Frimpong
    Addison, Yvonne Abena Afadua
    JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [27] The Impact of Mass Drug Administration on Lymphatic Filariasis
    Aboagye, Isaac Frimpong
    Addison, Yvonne Abena Afadua
    JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [28] Mass drug administration to treat lymphatic filariasis
    Ravindran, B
    LANCET, 2002, 359 (9321): : 1948 - 1948
  • [29] Outcomes of a two-drug chemotherapy regimen for retinoblastoma.
    Zage, P. E.
    Weinstein, J.
    Mets, M. B.
    Lasky, J. B.
    Goldman, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 517S - 517S
  • [30] Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma
    Zage, Peter E.
    Reitman, Aaron J.
    Seshadri, Roopa
    Weinstein, Joanna L.
    Mets, Marilyn B.
    Zeid, Janice Lasky
    Greenwald, Mark J.
    Strauss, Lewis C.
    Goldman, Stewart
    PEDIATRIC BLOOD & CANCER, 2008, 50 (03) : 567 - 572